Versigent director gets 14.65 dividend rights
Versigent PLC director received additional dividend-equivalent rights tied to prior RSU grants, reflecting a dividend paid on the company’s ordinary shares.
Rhea-AI Filing Summary
Versigent PLC (VGNT) reported that director Amy E. Alving acquired 14.65 Dividend Equivalent Rights on September 18, 2026. These rights accrued on existing restricted stock units due to a dividend declared and paid by Versigent and are each economically equivalent to one ordinary share, vesting on the same schedule as the related restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 14.65 shares
Grant/Award
1 txn
Insider
Alving Amy E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Dividend Equivalent Rights F1 | 14.65 | $0.00 | $0.00 |
Holdings After Transaction:
Dividend Equivalent Rights — 14.65 contracts (Direct)
Footnotes (1)
- F1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.
Key Figures
Dividend Equivalent Rights acquired: 14.65 rights
Price per Dividend Equivalent Right: $0.00 per right
Dividend Equivalent Rights held after transaction: 14.65 rights
+1 more
4 metrics
Dividend Equivalent Rights acquired
14.65 rights
Grant to director Amy E. Alving on September 18, 2026
Price per Dividend Equivalent Right
$0.00 per right
Reported acquisition price for the September 18, 2026 grant
Dividend Equivalent Rights held after transaction
14.65 rights
Total direct holdings of this derivative security after the grant
Underlying ordinary shares
14.65 shares
Each Dividend Equivalent Right is economically equivalent to one ordinary share
Key Terms
Dividend Equivalent Rights, restricted stock units, ordinary shares
3 terms
Dividend Equivalent Rights financial
"The dividend equivalent rights accrued on grants of restricted stock units"
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
restricted stock units financial
"accrued on grants of restricted stock units as a result of a dividend"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Versigent PLC (VGNT) report for Amy E. Alving?
Versigent reported that director Amy E. Alving acquired 14.65 Dividend Equivalent Rights on September 18, 2026. These derivative rights are tied to existing restricted stock units and are each economically equivalent to one ordinary share of Versigent.
What are the Dividend Equivalent Rights reported in VGNT’s Form 4?
The Form 4 states that Dividend Equivalent Rights accrued on grants of restricted stock units because Versigent declared and paid a dividend. Each right is the economic equivalent of one ordinary share and vests on the same schedule as the related restricted stock units.
How many Dividend Equivalent Rights did the Versigent (VGNT) director receive?
Director Amy E. Alving received 14.65 Dividend Equivalent Rights, with 14.65 rights reported as held directly after the transaction. Each right corresponds economically to one ordinary share of Versigent’s ordinary shares.
Was there any cash price paid for the VGNT Dividend Equivalent Rights grant?
No cash consideration is shown. The Form 4 reports 14.65 Dividend Equivalent Rights acquired at a stated price of $0.00 per right, reflecting an accrual triggered by a dividend on existing restricted stock units.
Do the VGNT Dividend Equivalent Rights have the same vesting as the underlying RSUs?
Yes. The footnote explains that the Dividend Equivalent Rights vest on the same schedule as the restricted stock units to which they relate, and each right is economically equivalent to one share of Versigent’s ordinary shares.
Was the Versigent (VGNT) Form 4 transaction under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmed. There is no indication in the Form 4 or its footnotes that this Dividend Equivalent Rights accrual was made under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.